Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease

Journal of the American College of Cardiology

Volumn 63, Issue 1, 2014, Pages 62-70

  Han, Yaling ^a   Zhu, Guoying ^b   Han, Lixian ^c   Hou, Fengxia ^d   Huang, Weijian ^e   Liu, Huiliang ^f   Gan, Jihong ^g   Jiang, Tiemin ^h   Li, Xiaoyan ⁱ   Wang, Wei ^j   Ding, Shifang ^k   Jia, Shaobin ^l   Shen, Weifeng ^m   Wang, Dongmei ⁿ   Sun, Ling ^o   Qiu, Jian ^p   Wang, Xiaozeng ^a   Li, Yi ^a   Deng, Jie ^a   Li, Jing ^a   Xu, Kai ^a   Xu, Bo ^q   Mehran, Roxana ^r   Huo, Yong ^s   more..

^a SHENYANG NORTHERN HOSPITAL   (China)

^b WUHAN ASIA HEART HOSPITAL   (China)

^c CANGZHOU CENTRAL HOSPITAL   (China)

^d Changchun Central Hospital   (China)

^e THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^f GENERAL HOSPITAL OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

^g Lanzhou Military WuluMuqi PLA Hospital   (China)

^h MEDICAL COLLEGE OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

ⁱ JINAN MILITARY GENERAL HOSPITAL   (China)

^j GUANGZHOU MEDICAL UNIVERSITY   (China)

^k WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

^l AFFILIATED HOSPITAL OF NINGXIA MEDICAL UNIVERSITY   (China)

^m SHANGHAI JIAO TONG UNIVERSITY   (China)

ⁿ BETHUNE INTERNATIONAL PEACE HOSPITAL   (China)

^o Fushun Central Hospital   (China)

^p GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^q FUWAI HOSPITAL   (China)

^r MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^s PEKING UNIVERSITY FIRST HOSPITAL   (China)

more..

Author keywords

angiography; contrast medium; diabetes mellitus; kidney; statins

Indexed keywords

CONTRAST MEDIUM; CREATININE; ROSUVASTATIN; ALBUMIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHRONIC KIDNEY DISEASE; CONTRAST INDUCED ACUTE KIDNEY INJURY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; RISK REDUCTION; SHORT COURSE THERAPY; ARTERIOGRAPHY; CHINA; CONTRAST INDUCED NEPHROPATHY; CORONARY ARTERY; GLOMERULUS FILTRATION RATE; INCIDENCE; KIDNEY FUNCTION; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; REHYDRATION;

ANGIOGRAPHY; CHRONIC KIDNEY DISEASE; CI-AKI; CKD; CONTRAST MEDIUM; CONTRAST-INDUCED ACUTE KIDNEY INJURY; DIABETES MELLITUS; DM; EGFR; ESTIMATED GLOMERULAR FILTRATION RATE; HIGH-SENSITIVITY C-REACTIVE PROTEIN; HSCRP; KIDNEY; LDL-C; LOW-DENSITY LIPOPROTEIN CHOLESTEROL; SCR; SERUM CREATININE; ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION; STATINS; STEMI; TC; TOTAL CHOLESTEROL;

ACUTE KIDNEY INJURY; ANGIOGRAPHY; CONTRAST MEDIA; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUOROBENZENES; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PYRIMIDINES; RENAL INSUFFICIENCY, CHRONIC; SULFONAMIDES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84891799028     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.09.017     Document Type: Article

References (42)

1. R. Solomon, and H.L. Dauerman Contrast-induced acute kidney injury Circulation 122 2010 2451 2455
2. P.A. McCullough, A. Adam, and C.R. Becker et al. Risk prediction of contrast-induced nephropathy Am J Cardiol 98 2006 27K 36K
3. S.L. Chen, J. Zhang, and F. Yei et al. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine Int J Cardiol 126 2008 407 413
4. J. Tumlin, F. Stacul, and A. Adam et al. Pathophysiology of contrast-induced nephropathy Am J Cardiol 98 2006 14K 20K
5. A. Giusti-Paiva, M.R. Martinez, and J.V. Felix et al. Simvastatin decreases nitric oxide overproduction and reverts the impaired vascular responsiveness induced by endotoxic shock in rats Shock 21 2004 271 275
6. P.M. Ridker, J. MacFadyen, M. Cressman, and R.J. Glynn Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial J Am Coll Cardiol 55 2010 1266 1273
7. M. Abe, N. Maruyama, Y. Yoshida, M. Ito, K. Okada, and M. Soma Efficacy analysis of the lipid-lowering and renoprotective effects of rosuvastatin in patients with chronic kidney disease Endocr J 58 2011 663 674
8. C. Quintavalle, D. Fiore, and F. De Micco et al. Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury Circulation 126 2012 3008 3016
9. G. Patti, A. Nusca, and M. Chello et al. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention Am J Cardiol 101 2008 279 285
10. S. Khanal, N. Attallah, and D.E. Smith et al. Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions Am J Med 118 2005 843 849
11. G. Patti, E. Ricottini, and A. Nusca et al. Short-term, high-dose atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty-contrast-induced nephropathy] trial Am J Cardiol 108 2011 1 7
12. R. Pappy, S. Stavrakis, T.A. Hennebry, and M.S. Abu-Fadel Effect of statin therapy on contrast-induced nephropathy after coronary angiography: a meta-analysis Int J Cardiol 151 2011 348 353
13. L. Zhang, Y. Lu, and B. Wu et al. Efficacy of statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis of randomised controlled trials Int J Clin Pract 65 2011 624 630
14. A. Toso, M. Maioli, and M. Leoncini et al. Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease Am J Cardiol 105 2010 288 292
15. S.H. Jo, B.K. Koo, and J.S. Park et al. Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial - a randomized controlled study Am Heart J 155 2008 499.e1 499.e8
16. W. Wijns, P. Kolh, and N. Danchin et al. Guidelines on myocardial revascularization Eur Heart J 31 2010 2501 2555
17. Y.C. Ma, L. Zuo, and J.H. Chen et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease J Am Soc Nephrol 17 2006 2937 2944
18. Standards of medical care in diabetes - 2012 Diabetes Care 35 Suppl 1 2012 S11 S63
19. S. Di Giulio, L. Meschini, and G. Triolo Dialysis outcome quality initiative (DOQI) guideline for hemodialysis adequacy Int J Artif Organs 21 1998 757 761
20. N.V. Zaytseva, M.S. Shamkhalova, and M.V. Shestakova et al. Contrast-induced nephropathy in patients with type 2 diabetes during coronary angiography: risk-factors and prognostic value Diabetes Res Clin Pract 86 Suppl 1 2009 S63 S69
21. X.C. Wang, X.H. Fu, and Y.B. Wang et al. Prediction of contrast-induced nephropathy in diabetics undergoing elective percutaneous coronary intervention: role of the ratio of contrast medium volume to estimated glomerular filtration rate Chin Med J (Engl) 124 2011 892 896
22. J.B. Layton, A.V. Kshirsagar, and R.J. Simpson Jr. et al. Effect of statin use on acute kidney injury risk following coronary artery bypass grafting Am J Cardiol 111 2013 823 828
23. M.A. Munoz, P.R. Maxwell, K. Green, D.W. Hughes, and R.L. Talbert Pravastatin versus simvastatin for prevention of contrast-induced nephropathy J Cardiovasc Pharmacol Ther 16 2011 376 379
24. S. Yusuf, S. Islam, and C.K. Chow et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE study): a prospective epidemiological survey Lancet 378 2011 1231 1243
25. M.L. Praught, and M.G. Shlipak Are small changes in serum creatinine an important risk factor? Curr Opin Nephrol Hypertens 14 2005 265 270
26. A. Lassnigg, D. Schmidlin, and M. Mouhieddine et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study J Am Soc Nephrol 15 2004 1597 1605
27. P.B. Persson, and A. Patzak Renal haemodynamic alterations in contrast medium-induced nephropathy and the benefit of hydration Nephrol Dial Transplant 20 Suppl 1 2005 i2 i5
28. S.J. Kim, M.R. Salem, N.J. Joseph, M.A. Madayag, R.P. Cavallino, and G.J. Crystal Contrast media adversely affect oxyhemoglobin dissociation Anesth Analg 71 1990 73 76
29. W. McClellan, S.L. Aronoff, and W.K. Bolton et al. The prevalence of anemia in patients with chronic kidney disease Curr Med Res Opin 20 2004 1501 1510
30. M.A. Brookhart, D.H. Solomon, R.J. Glynn, and P.M. Ridker Effect of rosuvastatin on hemoglobin levels in patients with anemia and low-grade inflammation: a post hoc analysis of the JUPITER trial J Clin Pharmacol 51 2011 1483 1487
31. S.J. Nicholls, C.M. Ballantyne, and P.J. Barter et al. Effect of two intensive statin regimens on progression of coronary disease N Engl J Med 365 2011 2078 2087
32. L.J. Scott, M.P. Curran, and D.P. Figgitt Rosuvastatin: a review of its use in the management of dyslipidemia Am J Cardiovasc Drugs 4 2004 117 138
33. J. Shepherd, D.G. Vidt, E. Miller, S. Harris, and J. Blasetto Safety of rosuvastatin: update on 16,876 rosuvastatin-treated patients in a multinational clinical trial program Cardiology 107 2007 433 443
34. P.M. Ridker, E. Danielson, and F.A. Fonseca et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
35. S.H. Deo, J.P. Fisher, and L.C. Vianna et al. Statin therapy lowers muscle sympathetic nerve activity and oxidative stress in patients with heart failure Am J Physiol Heart Circ Physiol 303 2012 H377 H385
36. J. Davignon Beneficial cardiovascular pleiotropic effects of statins Circulation 109 2004 III39 III43
37. J. Bonnet, R. McPherson, and A. Tedgui et al. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study Clin Ther 30 2008 2298 2313
38. Y.C. Tsai, C.C. Hung, and M.C. Kuo et al. Association of hsCRP, white blood cell count and ferritin with renal outcome in chronic kidney disease patients PLoS One 7 2012 e52775
39. E.R. Fox, E.J. Benjamin, and D.F. Sarpong et al. The relation of C-reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study BMC Nephrol 11 2010 1
40. A. Shankar, L. Sun, and B.E. Klein et al. Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study Kidney Int 80 2011 1231 1238
41. E. Lee, S. Ryan, and B. Birmingham et al. Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment Clin Pharmacol Ther 78 2005 330 341
42. M.A. Pfeffer, E.A. Burdmann, and C.Y. Chen et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease N Engl J Med 361 2009 2019 2032